| Courtney Roth, NP | |
|
1926 Alcoa Hwy Ste 370, Knoxville, TN 37920-1552 | |
| (865) 305-5622 | |
| Not Available |
| Full Name | Courtney Roth |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1926 Alcoa Hwy Ste 370, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033622725 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 23255 (Tennessee) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 23255 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health System, Inc. | 5294646378 | 526 |
News Archive
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has launched an enhanced dental drug interactions screening tool with a new Medication Safety Check feature, allowing professionals to screen for drug-drug, drug-allergy, and duplicate therapy interactions and review safe medication options.
Pre-registered and certified providers in the southwest, southeast, and north-central regions of the state have begun to receive the first doses of the live attenuated pandemic H1N1 influenza vaccine, also known by the brand name FluMist, the Pennsylvania Department of Health said today.
The drug Tysabri which was approved by the Food and Drug Administration (FDA) for the treatment of multiple sclerosis in November 2004, was taken off the market in late February, after two cases of progressive multifocal leukoencephalopathy, or PML, appeared in patients given the drug during clinical trials.
After an exhaustive process, the U.S. Preventive Services Task Force has announced its final recommendation on PSA-based prostate cancer screening. It finds that the known harms of screening outweigh the potential benefits for men who have no cancer symptoms. It notes that all screening studies have demonstrated considerable harms associated with screening, but only one major study found evidence that screening saves lives - and that study has some internal inconsistencies.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
› Verified 4 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has launched an enhanced dental drug interactions screening tool with a new Medication Safety Check feature, allowing professionals to screen for drug-drug, drug-allergy, and duplicate therapy interactions and review safe medication options.
Pre-registered and certified providers in the southwest, southeast, and north-central regions of the state have begun to receive the first doses of the live attenuated pandemic H1N1 influenza vaccine, also known by the brand name FluMist, the Pennsylvania Department of Health said today.
The drug Tysabri which was approved by the Food and Drug Administration (FDA) for the treatment of multiple sclerosis in November 2004, was taken off the market in late February, after two cases of progressive multifocal leukoencephalopathy, or PML, appeared in patients given the drug during clinical trials.
After an exhaustive process, the U.S. Preventive Services Task Force has announced its final recommendation on PSA-based prostate cancer screening. It finds that the known harms of screening outweigh the potential benefits for men who have no cancer symptoms. It notes that all screening studies have demonstrated considerable harms associated with screening, but only one major study found evidence that screening saves lives - and that study has some internal inconsistencies.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney Roth, NP 9307 Daybreak Dr, Knoxville, TN 37931-4202 Ph: (865) 567-6852 | Courtney Roth, NP 1926 Alcoa Hwy Ste 370, Knoxville, TN 37920-1552 Ph: (865) 305-5622 |
News Archive
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has launched an enhanced dental drug interactions screening tool with a new Medication Safety Check feature, allowing professionals to screen for drug-drug, drug-allergy, and duplicate therapy interactions and review safe medication options.
Pre-registered and certified providers in the southwest, southeast, and north-central regions of the state have begun to receive the first doses of the live attenuated pandemic H1N1 influenza vaccine, also known by the brand name FluMist, the Pennsylvania Department of Health said today.
The drug Tysabri which was approved by the Food and Drug Administration (FDA) for the treatment of multiple sclerosis in November 2004, was taken off the market in late February, after two cases of progressive multifocal leukoencephalopathy, or PML, appeared in patients given the drug during clinical trials.
After an exhaustive process, the U.S. Preventive Services Task Force has announced its final recommendation on PSA-based prostate cancer screening. It finds that the known harms of screening outweigh the potential benefits for men who have no cancer symptoms. It notes that all screening studies have demonstrated considerable harms associated with screening, but only one major study found evidence that screening saves lives - and that study has some internal inconsistencies.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
› Verified 4 days ago